Cargando…
Application of a systems pharmacology model for translational prediction of hERG‐mediated QTc prolongation
Drug‐induced QTc interval prolongation (Δ QTc) is a main surrogate for proarrhythmic risk assessment. A higher in vivo than in vitro potency for hERG‐mediated QTc prolongation has been suggested. Also, in vivo between‐species and patient populations’ sensitivity to drug‐induced QTc prolongation seem...
Autores principales: | Gotta, Verena, Yu, Zhiyi, Cools, Frank, van Ammel, Karel, Gallacher, David J., Visser, Sandra A. G., Sannajust, Frederick, Morissette, Pierre, Danhof, Meindert, van der Graaf, Piet H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226282/ https://www.ncbi.nlm.nih.gov/pubmed/28097003 http://dx.doi.org/10.1002/prp2.270 |
Ejemplares similares
-
Levofloxacin‐Induced QTc Prolongation Depends on the Time of Drug Administration
por: Kervezee, L, et al.
Publicado: (2016) -
The electric heart of hERG
por: Islas, León D.
Publicado: (2013) -
An Update on the Structure of hERG
por: Butler, Andrew, et al.
Publicado: (2020) -
Combining an in silico proarrhythmic risk assay with a tPKPD model to predict QTc interval prolongation in the anesthetized guinea pig assay
por: Morissette, Pierre, et al.
Publicado: (2020) -
The N-linker region of hERG1a upregulates hERG1b potassium channels
por: Johnson, Ashley A., et al.
Publicado: (2022)